Membership is open to individuals who hold U of U faculty appointments, and in some cases, cancer-focused faculty at other institutions. New Program Members and Associate Members are appointed based on 1) their potential to contribute to the scientific objectives of the Cancer Center and 2) research portfolios that are aligned with the goals of a Research Program. Continuing membership is granted based on actual contributions. Applications for membership are considered on a rolling basis.
Candidates submit a CV, biosketch, and application to the HCI Office of Research Administration. An HCI Program Leader presents the application to the members of the HCI Research Leadership Council, the candidate is discussed, and a vote is taken. A vote of the Research Leadership Council is advisory to the HCI Director, who has ultimate responsibility for appointment of Cancer Center members. Affiliate/Non-Program Aligned members are appointed by the HCI Director upon recommendation of a member of the Research Leadership Council. The Director’s approval is documented via the appointment letter sent to the new member.
Membership is reviewed annually, in conjunction with the CCSG progress report or competitive renewal. In addition, all Program Members and Associate Members who have space assigned by HCI undergo coordinated annual review by an HCI Senior Director and their department leadership; successful review is required to retain Cancer Center space and other resources. Assignment of HCI space is negotiated with department chairs and made under the authority of the HCI Director. Affiliate/Non-Program Aligned members are also reviewed annually; a change in appointment to Associate Member or Member requires review and recommendation for approval by the Research Leadership Council. Responsibility for final appointment decisions rests with the HCI Director.
Cancer Center Director
HCI Senior Directors
Neeraj Agarwal, MD
Clinical Research Innovation
Donald E. Ayer, PhD
Cancer Training and Career Enhancement
Rachel Ceballos, PhD
Community Outreach and Engagement
Max Loveless, MBA
Senior Administrative Director
Martin McMahon, PhD
Preclinical Translation
Kolawole S. Okuyemi, MD, MPH
Equity, Diversity, and Inclusion
Tracy Onega, PhD, MS
Population Sciences
Aik Choon Tan, PhD
Data Science
Alana Welm, PhD
Basic Science
Theresa Werner, MD
Clinical Research
David Wetter, PhD, MS
Cancer Health Equity Science
Program Leadership
Nuclear Control of Cell Growth and Differentiation
Jay Gertz, PhD
Co-Leader
Jared Rutter, PhD
Co-Leader
Cell Response and Regulation
Sheri Holmen, PhD
Leader
Experimental Therapeutics
Howard Colman, MD, PhD
Co-Leader
Martin McMahon, PhD
Co-Leader
Cancer Control and Population Sciences
Jennifer Doherty, MS, PhD
Co-Leader
Kathleen Mooney, PhD
Co-Leader